Biden-Appointed Judge Issues Insane Ruling on How ICE Should Handle Deranged MN Protesters
There Is No Law in the Jungle—or in American Cities, Either, Thanks to...
How China Sold America the Wind Turbine Scam
Food Wars
It’s Not a Wonderful Day in the Neighborhood: Criminal Monsters of Minneapolis
Israel’s October 7 Wartime Heroes, Both Celebrated and Unsung
The Highs and Lows of Nepalese-Israeli Relations
Industrial-Scale Fraud: How Government Spending Became a Cash Machine for Criminals
The World Prosperity Forum vs. World Economic Forum
Trump’s Fix for Breaking Healthcare’s Black Box
Democrats: All Opposition, No Positions
Wars Are Won by Defending Home First
10 Charged in Louisville–Detroit Drug Trafficking Conspiracy, Feds Say
Three Men Sentenced in Multi-State ATM Burglary Scheme
Treasury Slams 21 People, Groups With Sanctions for Allegedly Helping Terror Group
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement